Drug
Dapansutrile clinical trials
Also written OLT1177.
- studies test it
- 12
- open now
- 4
- in phase 3
- 1
- first study started
- 2012
Keep track of what changes. Save the dapansutrile studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
12 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 4
Olatec Therapeutics LLC (7) · April Salama, M.D. (1) · University of Virginia (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Olatec Therapeutics, Inc. (1) · Marc Donath (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses dapansutrile is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's DiseaseRecruitingPhase 2Cambridge University Hospitals NHS Foundation TrustNCT07157735Written as dapansutrile
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareRecruitingPhase 2/3Olatec Therapeutics, Inc.NCT05658575Written as Dapansutrile
- Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaRecruitingPhase 2Marc DonathNCT06047262Written as Dapansutrile
- Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MINot yet recruitingEarly Phase 1University of VirginiaNCT05880355Written as Dapansutrile
- A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced MelanomaActive, not recruitingPhase 1/2April Salama, M.D.NCT04971499Written as Dapansutrile
- Pilot Study of Dapansutrile Capsules in Schnitzler's SyndromeTerminatedPhase 2Olatec Therapeutics LLCNCT03595371Written as dapansutrile
- Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release SyndromeTerminatedPhase 2Olatec Therapeutics LLCNCT04540120Written as dapansutrile capsules
- Study of Dapansutrile Capsules in Heart FailureCompletedPhase 1Olatec Therapeutics LLCNCT03534297Written as dapansutrile capsules
- Study of OLT1177 Gel to Treat Moderate to Severe OA Knee PainCompletedPhase 2Olatec Therapeutics LLCNCT02104050Written as OLT1177 Gel
- Phase 1 Safety and PK Study of OLT1177 CapsulesCompletedPhase 1Olatec Therapeutics LLCNCT02134964Written as OLT1177 Capsules
- Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the KneeCompletedPhase 2Olatec Therapeutics LLCNCT01768975Written as OLT1177 Gel
- Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy SubjectsCompletedPhase 1Olatec Therapeutics LLCNCT01636141Written as OLT1177 Gel
Codes
What other systems call dapansutrile · ClinicalTrials.gg INT000970
- MeSH (NLM) C000627877dapansutrileConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2Z03364G96DAPANSUTRILEConfirmed FDA, NLM, Wikidata
- Wikidata Q27255815dapansutrileConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166608DapansutrileOne source FDA
- DrugBank DB16130One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000627877 | dapansutrile | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2Z03364G96 | DAPANSUTRILE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27255815 | dapansutrile | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166608 | Dapansutrile | One source FDA |
| DrugBank | DB16130 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.